Real-life Use of Bexarotene for T-cell Cutaneous Lymphoma Management: Efficacy and Tolerance with Low Doses Por Jacques Rouanet, Ines Joulie, Celine Lambert, Michel D'Incan

Obter o texto integral

Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms Por Hussein Akil, Jacques Rouanet, Claire Viallard, Sophie Besse, Philippe Auzeloux, Jean-Michel Chezal, Elisabeth Miot-Noirault, Mercedes Quintana, Françoise Degoul

Obter o texto integral

Assessment of 99mTc-NTP 15-5 uptake on cartilage, a new proteoglycan tracer: Study protocol for a phase I trial (CARSPECT) Por Emilie Thivat, Emilie Thivat, Emilie Thivat, Marion Chanchou, Marion Chanchou, Sylvain Mathieu, Sophie Levesque, Sophie Levesque, Sophie Levesque, Tommy Billoux, Tommy Billoux, Philippe Auzeloux, Nicolas Sas, Nicolas Sas, Ioana Molnar, Ioana Molnar, Ioana Molnar, Elodie Jouberton, Elodie Jouberton, Jacques Rouanet, Jacques Rouanet, Giovanna Fois, Lydia Maigne, Marie-Josephe Galmier, Frédérique Penault-Llorca, Frédérique Penault-Llorca, Frédérique Penault-Llorca, Elisabeth Miot-Noirault, Xavier Durando, Xavier Durando, Xavier Durando, Xavier Durando, Florent Cachin, Florent Cachin, Florent Cachin

Obter o texto integral

Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol Por Emilie Thivat, Jacques Rouanet, Philippe Auzeloux, Nicolas Sas, Elodie Jouberton, Sophie Levesque, Tommy Billoux, Sandrine Mansard, Ioana Molnar, Marion Chanchou, Giovanna Fois, Lydia Maigne, Jean-Michel Chezal, Elisabeth Miot-Noirault, Michel D’Incan, Xavier Durando, Florent Cachin

Obter o texto integral